Suguru Okami

Affiliations

AstraZeneca, Osaka, Japan.

ORCID: 0000-0003-4402-0209

Publications (6)

Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study.

Diabetes, obesity & metabolism

Avec: Kåre I Birkeland , Johan Bodegard , Amitava Banerjee , Dae Jung Kim , Anna Norhammar , Jan W Eriksson , Marcus Thuresson , Suguru Okami , Kyoung Hwa Ha , Nils Kossack , Jil Billy Mamza , Ruiqi Zhang , Toshitaka Yajima , Issei Komuro , Takashi Kadowaki

Lower heart failure and chronic kidney disease risks associated with sodium-glucose cotransporter-2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases.

Diabetes, obesity & metabolism

Avec: Issei Komuro , Takashi Kadowaki , Johan Bodegård , Marcus Thuresson , Suguru Okami , Toshitaka Yajima

Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan.

Scientific reports

Avec: Suguru Okami , Coralie Lecomte , Hanaya Raad , Mireia Aguila , Zuzana Mohrova , Makiko Takeichi , Takanori Tsuchiya , Christoph Ohlmeier , Thomas Evers , Alexander Michel

Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.

Diabetes, obesity & metabolism

Avec: Kåre I Birkeland , Johan Bodegard , Jan W Eriksson , Anna Norhammar , Hermann Haller , Gerard C M Linssen , Amitava Banerjee , Marcus Thuresson , Suguru Okami , Elena Garal-Pantaler , Jetty Overbeek , Jil Billy Mamza , Ruiqi Zhang , Toshitaka Yajima , Issei Komuro , Takashi Kadowaki

Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries.

Diabetes, obesity & metabolism

Avec: Anna Norhammar , Johan Bodegard , Jan W Eriksson , Hermann Haller , Gerard C M Linssen , Amitava Banerjee , Avraham Karasik , Pavlos Mamouris , Navdeep Tangri , Tiago Taveira-Gomes , Aldo P Maggioni , Manuel Botana , Marcus Thuresson , Suguru Okami , Toshitaka Yajima , Takashi Kadowaki , Kåre I Birkeland , Auteur inconnu

Risk-Benefit Balance of Renin-Angiotensin-Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia.

Journal of clinical medicine

Avec: Shun Kohsaka , Suguru Okami , Naru Morita , Toshitaka Yajima

Réseau de co-auteurs

Toshitaka Yajima 5 collaborations

Marcus Thuresson 4 collaborations

Takashi Kadowaki 4 collaborations

Kåre I Birkeland 3 collaborations

Johan Bodegard 3 collaborations

Amitava Banerjee 3 collaborations

Anna Norhammar 3 collaborations

Jan W Eriksson 3 collaborations

Issei Komuro 3 collaborations

Jil Billy Mamza 2 collaborations

Ruiqi Zhang 2 collaborations

Hermann Haller 2 collaborations

Gerard C M Linssen 2 collaborations

Dae Jung Kim 1 collaboration

Kyoung Hwa Ha 1 collaboration

Nils Kossack 1 collaboration

Johan Bodegård 1 collaboration

Coralie Lecomte 1 collaboration

Hanaya Raad 1 collaboration

Mireia Aguila 1 collaboration

Zuzana Mohrova 1 collaboration

Makiko Takeichi 1 collaboration

Takanori Tsuchiya 1 collaboration

Christoph Ohlmeier 1 collaboration

Thomas Evers 1 collaboration

Alexander Michel 1 collaboration

Elena Garal-Pantaler 1 collaboration

Jetty Overbeek 1 collaboration

Avraham Karasik 1 collaboration

Pavlos Mamouris 1 collaboration

Navdeep Tangri 1 collaboration

Tiago Taveira-Gomes 1 collaboration

Aldo P Maggioni 1 collaboration

Manuel Botana 1 collaboration

None None 1 collaboration

Shun Kohsaka 1 collaboration

Naru Morita 1 collaboration